R-044 Blemish Fix
NDC Package 24623-044-23

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

R-044 Blemish Fix is cleanse the skin thoroughly before applying medication.Shake well before use.Apply a thin layer directly to affected areas one to three times daily. Marketed by Cbi Laboratories, Inc, this product is identified by NDC 24623-044 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
24623-044-23
Package Description
6.8 mL in 1 BOTTLE, GLASS
Product Code
11-Digit Billing Format
24623004423
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
R-044 Blemish Fix
Dosage Form
-
Usage Information
Cleanse the skin thoroughly before applying medication.Shake well before use.Apply a thin layer directly to affected areas one to three times daily.

Regulatory & Marketing

Labeler Name
Cbi Laboratories, Inc
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-28-2006
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24623-044-23 identifies a specific commercial package of 6.8 ml in 1 bottle, glass of R-044 Blemish Fix, labeled by Cbi Laboratories, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cbi Laboratories, Inc on March 28, 2006. The current certification is valid through December 31, 2017.

How is this Cbi Laboratories, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24623004423. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24623-044-23
11-Digit CMS (5-4-2)
24623-0044-23

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.